Signet Healthcare Partners Completes Growth Equity Investment in Juno Pharmaceuticals Corp.
Juno Pharmaceuticals Corp., a Canadian specialty generics pharmaceuticals company, announced that it had received a strategic growth investment from Signet Healthcare Partners, a New York-based health-care growth equity firm.
These proceeds will support Juno in expanding its complex and high-value generic and biosimilar portfolio and accelerating growth.
Aird & Berlis LLP acted as legal counsel for Juno Pharmaceuticals Corp. with a team including Richard Epstein, Lorway Gosse, Aaron Bains (Corporate/Commercial) and Francesco Gucciardo (Tax).
-
BioFull bio
Prior to joining Aird & Berlis, Richard was an entrepreneur, operating various car leasing, automotive and light manufacturing businesses in the T...
-
BioFull bio
Lorway passionately advocates for his clients’ interests, providing sound, proactive advice while assisting clients in navigating commercial rea...
-
BioFull bio
With an international background and hands-on business experience, Aaron provides practical and strategic advice to a broad range of domestic and inte...
-
BioFull bio
Francesco’s clients rely on his sophisticated knowledge of domestic and international tax to further their business objectives.
